Skip to main content
. 2021 Dec 25;12(1):29. doi: 10.3390/life12010029
BMI Body mass index
CV Cardiovascular
cAMP Cyclic-adenosine-monophosphate
CVOT Cardiovascular outcome trial
DPP-4 Dipeptidyl peptidase 4
FDA United States Food and Drug Administration
FFA Free fatty acids
GIP Glucose-dependent insulinotropic polypeptide
GIPRs GIP receptors
GLP-1 Glucagon-like peptide-1
GLP-1 R Glucagon-like peptide-1 receptor
GLP-1 RA Glucagon-like peptide-1 receptor agonists
GR Glucagon receptor
HbA1c Glycated hemoglobin A1c
i.v. Intravenous
MACE Major cardiovascular events
MI Myocardial infarction
OGTT Oral glucose tolerance test
PEG Polyethylene glycol
SGLT Sodium-glucose co-transporter type
SD Standard deviation
T2DM Type 2 diabetes mellitus